These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 19797923)

  • 1. Intracellular localization of (99m)Tc-d,l-HMPAO in rat blood.
    Al-Saeedi FJ; Gopinath S
    Med Princ Pract; 2009; 18(6):466-9. PubMed ID: 19797923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of stabilized 99mTc-D,L-HMPAO stored in vials and syringes.
    Del Carmen Plancha-Mansanet M; Caballero-Calabuig E; Félix-Fontestad J; Reyes-Ojeda MD; Sopena-Novales P; Abreu-Sánchez P; Del Carmen Cano-Terol M; Sopena-Monforte R
    J Nucl Med Technol; 2008 Dec; 36(4):213-6. PubMed ID: 19008289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-HMPAO as a tracer of cerebral blood flow in newborn infants.
    Børch K; Greisen G
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):448-54. PubMed ID: 9143227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the stability of (99m)Tc-ECD and stabilized (99m)Tc-HMPAO stored in syringes.
    Koslowsky IL; Brake SE; Bitner SJ
    J Nucl Med Technol; 2001 Dec; 29(4):197-200. PubMed ID: 11756532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metabolic alterations on the accumulation of technetium-99m-labeled d,l-HMPAO in slices of rat cerebral cortex.
    Ahn CS; Tow DE; Yu CC; Greene RW
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):324-31. PubMed ID: 8113327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-tricarbonyl labeled agents for cell labeling: development, biodistribution in normal mice and preliminary in vitro evaluation.
    Fonge H; Jin L; Cleynhens J; Bormans G; Verbruggen A
    Bioorg Med Chem; 2010 Jan; 18(1):396-402. PubMed ID: 19926292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO): basic kinetic studies of a tracer of cerebral blood flow.
    Andersen AR
    Cerebrovasc Brain Metab Rev; 1989; 1(4):288-318. PubMed ID: 2701656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of technetium-99m-HMPAO and xenon-133 measurements of regional cerebral blood flow by SPECT.
    Payne JK; Trivedi MH; Devous MD
    J Nucl Med; 1996 Oct; 37(10):1735-40. PubMed ID: 8862321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of technetium-99m-d,1-HMPAO to radiolysis in aqueous solutions.
    Tubergen K; Corlija M; Volkert WA; Holmes RA
    J Nucl Med; 1991 Jan; 32(1):111-5. PubMed ID: 1988613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution study and identification of inflammatory sites using nanocapsules labeled with (99m)Tc-HMPAO.
    Pereira MA; Mosqueira VC; Carmo VA; Ferrari CS; Reis EC; Ramaldes GA; Cardoso VN
    Nucl Med Commun; 2009 Sep; 30(9):749-55. PubMed ID: 19593235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake kinetics of 99mTc-MAG3-antisense oligonucleotide to PCNA and effect on gene expression in vascular smooth muscle cells.
    Zhang YR; Zhang YX; Cao W; Lan XL
    J Nucl Med; 2005 Jun; 46(6):1052-8. PubMed ID: 15937319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of the secretion of technetium-99m hexamethylpropylene amine oxime into breast milk.
    Marshall DS; Newberry NR; Ryan PJ
    Eur J Nucl Med; 1996 Dec; 23(12):1634-5. PubMed ID: 8929318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of antioxidative ability in brain: technetium-99m-meso-HMPAO as an imaging agent for glutathione localization.
    Sasaki T; Toyama H; Oda K; Ogihara-Umeda I; Nishigori H; Senda M
    J Nucl Med; 1996 Oct; 37(10):1698-701. PubMed ID: 8862315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake mechanism of technetium-99m-d, 1-HMPAO in cell cultures of the dissociated postnatal rat cerebellum.
    Suess E; Huck S; Reither H; Hörtnagl H; Angelberger P
    J Nucl Med; 1992 Jan; 33(1):108-14. PubMed ID: 1730973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m hexamethylpropylene amine oxime lung scintigraphy findings in low-dose amiodarone therapy.
    Kaya GC; Ertay T; Tuna B; Bekis R; Tasci C; Sayit E; Yilmaz O; Kargi A; Durak H
    Lung; 2006; 184(2):57-61. PubMed ID: 16622774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple procedure for red blood cell labeling with Tc-99m HMPAO. Preliminary clinical results.
    Vorne M; Laitinen R
    Clin Nucl Med; 1992 Jan; 17(1):14-7. PubMed ID: 1311998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilisation of high-activity 99mTc-d,l-HMPAO preparations with cobalt chloride and their biological behaviour.
    Mang'era KO; Vanbilloen HP; Schiepers CW; Verbruggen AM
    Eur J Nucl Med; 1995 Oct; 22(10):1163-72. PubMed ID: 8542901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Approach for
    Liu M; Zhao ZQ; Fang W; Liu S
    Bioconjug Chem; 2017 Dec; 28(12):2998-3006. PubMed ID: 29148726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular localization of 99Tcm-d,l-HMPAO and 201Tl-DDC in rat brain.
    Costa DC; Lui D; Sinha AK; Jarritt PH; Ell PJ
    Nucl Med Commun; 1989 Jul; 10(7):459-66. PubMed ID: 2552362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocytes as a predominant cellular site of (99m)Tc-HMPAO retention.
    Zerarka S; Pellerin L; Slosman D; Magistretti PJ
    J Cereb Blood Flow Metab; 2001 Apr; 21(4):456-68. PubMed ID: 11323531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.